News and features

Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.

If you’re a journalist and want to find out more, you can contact our media relations team.

ICR Logo
Scientists find previously unknown survival signals that can keep cancer cells alive

30/01/15

Scientists have discovered that a key cancer protein can promote the survival of cancer cells – even when targeted by drugs designed to block its main function.
dna
‘Bad’ genetic changes outweigh ‘good’ for blood cancer patients

28/01/15

Patients with myeloma whose cancer cells carry genetic changes associated with both good and bad prognosis have outcomes similar to those with bad risk changes alone, a new ICR study reports.
ICR Logo
Using sound waves to zap away cancer

27/01/15

Ultrasound can be used to supply focused energy in the form of heat in a technique called high-intensity focused ultrasound. The energy from this technique can be focused and used to selectively target tumour tissue.
clinical trial
Cancer drugs should be licensed on smaller trials to cut prices

24/01/15

Earlier licensing could speed progress and reduce drug costs, global experts say.
Sarcoma team
Chris Lucas Trust donates £300,000 to rhabdomyosarcoma research

22/01/15

The Chris Lucas Trust has made another generous pledge of £300,000 to support rhabdomyosarcoma research at the ICR.
dna-sequence
Major study links gene to drug resistance in testicular cancer

22/01/15

A major research study has uncovered several new genetic mutations that could drive testicular cancer – and also identified a gene which may contribute to tumours becoming resistant to current treatments.
HIFU
Sound waves being used to heat-treat cancer pain

21/01/15

A pioneering clinical trial is testing whether focusing high-frequency sound waves onto the surface of bone where cancer has spread can burn away the source of pain.
microRNA
Using micro-RNAs in cancer research: little strands of genetic material with big promise

21/01/15

After the human genome project was completed, many people were surprised to learn that 98% of genome did not code for any functional genes. However, this ‘junk DNA’ holds surprising secrets, and is actually a hub of crucial gene-controlling activity.
Sean Chinn, an ICR supporter at the summit of Mount Kilimanjaro
Grandfather’s memory inspires challenge to Mount Kilimanjaro

20/01/15

Fundraiser Sean Chinn embarked on the challenge of a lifetime when he set off to Tanzania to climb to the summit of Mount Kilimanjaro. He raised an impressive £3,800 for world-leading cancer research at the ICR.
ICR Logo
New pathway identified for debilitating skin condition

19/01/15

ICR scientists have discovered that a type of signal within tumour cells is critical to the development of a rare and debilitating inherited skin condition.
Acute lymphoblastic leukaemia
Identical twins reveal new clues to origins of childhood leukaemia

16/01/15

A new study of identical twins with leukaemia has traced its earliest genetic changes all the way back to immature cells from the immune system, which develop before children are even born.
Breast cancer cell
Research identifies new system for predicting treatment outcome in breast cancer

12/01/15

Combining two measures of breast cancer’s response to treatment provides a better prediction of long-term outcome following chemotherapy than existing assessments, a new study reports.

Make a donation today

A monthly gift can help support our research over several years, so it has the maximum possible benefit for people with cancer.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

With your generous support, we can continue making more discoveries, finding more cures, and saving more lives.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

Our research centres & divisions

Through our close partnerships with The Royal Marsden and other key UK institutions, we're leading a wide breadth of cancer research across eight divisions and more than 25 research centres and strategic initiatives.